References
- Montserrat E. New prognostic markers in CLL. Hematol (Am Soc Hematol Educ Program) 2006; 279–284
- Rosenwald A, Chuang E Y, Davis R E, Wiestner A, Alizadeh A A, Arthur D C, et al. Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression response. Blood 2004; 104: 1428–1434
- Turgut B, Vural O, Pala F S, Pamuk G E, Tabakcioglu K, Demir M, et al. 17p deletion is associated with resistance of B-cell chronic lymphocytic leukemia cells to in vitro fludarabine-induced apoptosis. Leuk Lymphoma 2007; 48: 311–320
- Valganon M, Giraldo P, Agirre X, Larrayoz M J, Rubio-Martinez A, Rubio-Felix D, et al. p53 aberrations do not predict individual response to fludarabine in patients with B-cell chronic lymphocytic leukaemia in advanced stages Rai III/IV. Br J Haematol 2005; 129: 53–59
- Byrd J C, Gribben J G, Peterson B L, Grever M R, Lozanski G, Lucas D M, et al. Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: justification for risk-adapted therapy. J Clin Oncol 2006; 24: 437–443
- Grever M R, Lucas D M, Dewald G W, Neuberg D S, Reed J C, Kitada S, et al. Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997. J Clin Oncol 2007; 25: 799–804
- Ritgen M, Lange A, Stilgenbauer S, Dohner H, Bretscher C, Bosse H, et al. Unmutated immunoglobulin variable heavy-chain gene status remains an adverse prognostic factor after autologous stem cell transplantation for chronic lymphocytic leukemia. Blood 2003; 101: 2049–2053
- Guillaume N, Gouilleux-Gruart V, Claisse J, Troussard X, Lepelley P, Damaj G, et al. Multi-drug resistance mediated by P-glycoprotein overexpression is not correlated with ZAP-70/CD38 expression in B-cell chronic lymphocytic leukemia. Leuk Lymphoma 2007; 48: 1556–1560
- Matthews C, Catherwood M A, Larkin A M, Clynes M, Morris T C, Alexander H D. MDR-1, but not MDR-3 gene expression, is associated with unmutated IgVH genes and poor prognosis chromosomal aberrations in chronic lymphocytic leukemia. Leuk Lymphoma 2006; 47: 2308–2313
- Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1910–1916